Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.

Lezcano E, Gómez-Esteban JC, Tijero B, Bilbao G, Lambarri I, Rodriguez O, Villoria R, Dolado A, Berganzo K, Molano A, de Gopegui ER, Pomposo I, Gabilondo I, Zarranz JJ.

J Neurol. 2016 May;263(5):895-905. doi: 10.1007/s00415-016-8077-4. Epub 2016 Mar 10.

PMID:
26964542
2.

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.

Tijero B, Gabilondo I, Lezcano E, Teran-Villagrá N, Llorens V, Ruiz-Martinez J, Marti-Masso JF, Carmona M, Luquin MR, Berganzo K, Fernandez I, Fernandez M, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2015 Jul;21(7):717-22. doi: 10.1016/j.parkreldis.2015.04.012. Epub 2015 Apr 23.

PMID:
25960264
3.

Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.

Somme JH, Molano Salazar A, Gonzalez A, Tijero B, Berganzo K, Lezcano E, Fernandez Martinez M, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2015 May;21(5):494-9. doi: 10.1016/j.parkreldis.2015.02.019. Epub 2015 Mar 2.

PMID:
25840672
4.

Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Pérez T, Tijero B, Gabilondo I, Luna A, Llorens V, Berganzo K, Acera M, Gonzalez A, Sanchez-Ferro A, Lezcano E, Zarranz JJ, Gómez-Esteban JC.

J Hum Hypertens. 2015 Oct;29(10):604-9. doi: 10.1038/jhh.2014.131. Epub 2015 Jan 29.

PMID:
25631216
5.

Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups.

Berganzo K, Tijero B, González-Eizaguirre A, Somme J, Lezcano E, Gabilondo I, Fernandez M, Zarranz JJ, Gómez-Esteban JC.

Neurologia. 2016 Nov - Dec;31(9):585-591. doi: 10.1016/j.nrl.2014.10.010. Epub 2014 Dec 17. English, Spanish.

6.

Impulse control and repetitive behaviors in Parkinson's disease - are there differences in the relation to dopamine agonist treatment?

Somme JH, Gómez-Esteban JC, Tijero B, Berganzo K, Lezcano E, Zarranz JJ.

J Neurol Sci. 2014 Oct 15;345(1-2):252-3. doi: 10.1016/j.jns.2014.07.004. Epub 2014 Jul 9. No abstract available.

PMID:
25048409
7.

Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats.

Lezcano EJ, Iñigo P, Larraga AM, Barranquero C, Gimenez I, Osada J.

Diabetol Metab Syndr. 2014 Jan 27;6(1):10. doi: 10.1186/1758-5996-6-10.

8.

Advanced Parkinson's disease: clinical characteristics and treatment. Part II.

Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R.

Neurologia. 2013 Nov-Dec;28(9):558-83. doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21. Review. English, Spanish.

9.

[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)].

Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R.

Neurologia. 2013 Oct;28(8):503-21. doi: 10.1016/j.nrl.2013.05.001. Epub 2013 Jul 13. Review. Spanish.

10.

Autonomic dysfunction in parkinsonian LRRK2 mutation carriers.

Tijero B, Gómez Esteban JC, Somme J, Llorens V, Lezcano E, Martinez A, Rodríguez T, Berganzo K, Zarranz JJ.

Parkinsonism Relat Disord. 2013 Oct;19(10):906-9. doi: 10.1016/j.parkreldis.2013.05.008. Epub 2013 Jun 10.

PMID:
23764467
11.

Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: are they related?

Berganzo K, Díez-Arrola B, Tijero B, Somme J, Lezcano E, Llorens V, Ugarriza I, Ciordia R, Gómez-Esteban JC, Zarranz JJ.

J Neurol. 2013 Jul;260(7):1752-6. doi: 10.1007/s00415-013-6859-5. Epub 2013 Feb 15.

PMID:
23412356
12.

The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.

Somme J, Gómez-Esteban JC, Tijero B, Berganzo K, Lezcano E, Zarranz JJ.

Clin Neurol Neurosurg. 2013 Aug;115(8):1230-3. doi: 10.1016/j.clineuro.2012.11.013. Epub 2012 Dec 17.

PMID:
23253819
13.

Management of children with brain tumors in Paraguay.

Baskin JL, Lezcano E, Kim BS, Figueredo D, Lassaletta A, Perez-Martinez A, Madero L, Caniza MA, Howard SC, Samudio A, Finlay JL.

Neuro Oncol. 2013 Feb;15(2):235-41. doi: 10.1093/neuonc/nos291. Epub 2012 Nov 29.

14.

Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene.

Tijero B, Gómez-Esteban JC, Lezcano E, Fernández-González C, Somme J, Llorens V, Martínez A, Ruiz-Martínez J, Foncea N, Escalza I, Berganzo K, Aniel-Quiroga MA, Ruiz V, Terán N, Kaufmann H, Zarranz JJ.

Parkinsonism Relat Disord. 2013 Jan;19(1):95-100. doi: 10.1016/j.parkreldis.2012.08.001. Epub 2012 Sep 19.

PMID:
23000061
15.

SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.

Berganzo K, Tijero B, Somme JH, Llorens V, Sánchez-Manso JC, Low D, Iodice V, Vichayanrat E, Mathias CJ, Lezcano E, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2012 Jan;18(1):45-8. doi: 10.1016/j.parkreldis.2011.08.018. Epub 2011 Sep 9.

PMID:
21908227
16.

Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).

Somme JH, Gomez-Esteban JC, Molano A, Tijero B, Lezcano E, Zarranz JJ.

J Neurol Sci. 2011 Nov 15;310(1-2):86-9. doi: 10.1016/j.jns.2011.07.047. Epub 2011 Aug 31.

PMID:
21880335
17.

Relationship between sleep and dysautonomic symptoms assessed by self-report scales.

Tijero B, Somme J, Gómez-Esteban JC, Berganzo K, Adhikari I, Lezcano E, Bilbao I, Garamendi I, Zarranz JJ.

Mov Disord. 2011 Aug 15;26(10):1967-8. doi: 10.1002/mds.23761. Epub 2011 May 12. No abstract available.

PMID:
21567459
18.

[Device thrombosis during the percutaneous closure of a patent foramen ovale].

Lezcano EJ, Ruiz JR, Lacambra I.

Rev Esp Cardiol. 2011 Jun;64(6):540-1. doi: 10.1016/j.recesp.2010.11.002. Epub 2011 Mar 16. Spanish. No abstract available.

19.

Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease.

Gómez-Esteban JC, Tijero B, Somme J, Ciordia R, Berganzo K, Rouco I, Bustos JL, Valle MA, Lezcano E, Zarranz JJ.

J Neurol. 2011 Mar;258(3):494-9. doi: 10.1007/s00415-010-5786-y. Epub 2010 Oct 19.

PMID:
20957384
20.

Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).

Tijero B, Gomez-Esteban JC, Llorens V, Lezcano E, Gonzalez-Fernández MC, de Pancorbo MM, Ruiz-Martinez J, Cembellin JC, Zarranz JJ.

Clin Auton Res. 2010 Aug;20(4):267-9. doi: 10.1007/s10286-010-0068-4. Epub 2010 May 5.

PMID:
20443127
21.

Factors influencing the symmetry of Parkinson's disease symptoms.

Gómez-Esteban JC, Tijero B, Ciordia R, Berganzo K, Somme J, Lezcano E, Zarranz JJ.

Clin Neurol Neurosurg. 2010 May;112(4):302-5. doi: 10.1016/j.clineuro.2009.12.017. Epub 2010 Jan 18.

PMID:
20083340
22.

Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study.

Valldeoriola F, Regidor I, Mínguez-Castellanos A, Lezcano E, García-Ruiz P, Rojo A, Salvador A, Castro A, Grandas F, Kulisevsky J, Martí MJ, Martínez-Martín P, Relova L, Rumià J, Cámara A, Burguera JA, Linazasoro G, de Val JL, Obeso J, Rodríguez-Oroz MC, Tolosa E; Grupo ESpañol para el EStudio de la EStimulación PALidal en la DIStonía.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):65-9. doi: 10.1136/jnnp.2009.174342. Epub 2009 Sep 10.

PMID:
19744963
23.

Application of depression criteria (DSM-IV) in patients with Parkinson's disease.

Gómez-Esteban JC, Tijero B, Somme J, Bilbao I, Fernández J, Boyero S, Velasco F, Lezcano E, Zarranz JJ.

Clin Neurol Neurosurg. 2009 Oct;111(8):665-9. doi: 10.1016/j.clineuro.2009.05.014. Epub 2009 Jul 8.

PMID:
19589638
24.

[Neuroprotection in Parkinson's disease: analysis though group of experts' methodology].

Linazasoro G, Sesar A, Valldeoriola F, Compta Y, Herrero MT, Martínez Castrillo JC, López Lozano JJ, Bergaretxe A, Vela L, Fernández JM, Castro A, Kulisevski J, Lezcano E, Vaamonde J, López Del Val J, Chacón J, Vivancos F, Luquin R, Aguilar M, Burguera JA, Salvador C, Menéndez Guisasola L, Catalán MJ, Mir P, Campos V, Grandas F, Mínguez A, Balaguer E, Yáñez R, Leiva C, García Ruiz P, Cubo E.

Neurologia. 2009 Mar;24(2):113-24. Spanish.

PMID:
19322690
25.

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.

Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP.

Neurogenetics. 2009 Oct;10(4):347-53. doi: 10.1007/s10048-009-0187-z. Epub 2009 Mar 24.

26.

[Motor fluctuations and dyskinesias in Parkinson's disease: variables that discriminate both complications in a sample of 285 patients].

Gómez JC, Rouco I, Velasco F, Tijero B, Garamendi I, Lezcano E, Zarranz JJ.

Neurologia. 2008 Oct;23(8):494-8. Spanish.

PMID:
18770057
27.

Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene.

Gómez-Esteban JC, Lezcano E, Zarranz JJ, González C, Bilbao G, Lambarri I, Rodríguez O, Garibi J.

Neurosurgery. 2008 Apr;62(4):857-62; discussion 862-3. doi: 10.1227/01.neu.0000318171.82719.35.

PMID:
18496192
28.

Restless legs syndrome in Parkinson's disease.

Gómez-Esteban JC, Zarranz JJ, Tijero B, Velasco F, Barcena J, Rouco I, Lezcano E, Lachen MC, Jauregui A, Ugarte A.

Mov Disord. 2007 Oct 15;22(13):1912-6.

PMID:
17579369
29.

Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.

González-Fernández MC, Lezcano E, Ross OA, Gómez-Esteban JC, Gómez-Busto F, Velasco F, Alvarez-Alvarez M, Rodríguez-Martínez MB, Ciordia R, Zarranz JJ, Farrer MJ, Mata IF, de Pancorbo MM.

Parkinsonism Relat Disord. 2007 Dec;13(8):509-15. Epub 2007 May 30.

PMID:
17540608
30.

Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.

Gómez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, Rouco I, Garamendi I.

Eur Neurol. 2007;57(3):161-5. Epub 2007 Jan 10.

PMID:
17213723
31.

Monozygotic twins suffering from Huntington's disease show different cognitive and behavioural symptoms.

Gómez-Esteban JC, Lezcano E, Zarranz JJ, Velasco F, Garamendi I, Pérez T, Tijero B.

Eur Neurol. 2007;57(1):26-30. Epub 2006 Nov 14.

PMID:
17108691
32.

Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.

Gómez-Esteban JC, Zarranz JJ, Lezcano E, Velasco F, Ciordia R, Rouco I, Losada J, Bilbao I.

Mov Disord. 2006 Jul;21(7):983-8.

PMID:
16602112
33.

[Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].

Rouco I, Gómez JC, Lezcano E, Aniel-Quiroga MA, Velasco F, Barcena J, Pérez Bas M, Hurtado P, Cruz Lachén M, Zarranz JJ.

Neurologia. 2006 Apr;21(3):119-23. Spanish.

PMID:
16575624
34.

Phenotypic variability in familial prion diseases due to the D178N mutation.

Zarranz JJ, Digon A, Atarés B, Rodríguez-Martínez AB, Arce A, Carrera N, Fernández-Manchola I, Fernández-Martínez M, Fernández-Maiztegui C, Forcadas I, Galdos L, Gómez-Esteban JC, Ibáñez A, Lezcano E, López de Munain A, Martí-Massó JF, Mendibe MM, Urtasun M, Uterga JM, Saracibar N, Velasco F, de Pancorbo MM.

J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1491-6.

35.

Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome.

Zarranz JJ, Gómez-Esteban JC, Atarés B, Lezcano E, Forcadas M.

Mov Disord. 2006 Jan;21(1):107-11.

PMID:
16114023
36.

Abnormal sleep architecture is an early feature in the E46K familial synucleinopathy.

Zarranz JJ, Fernández-Bedoya A, Lambarri I, Gómez-Esteban JC, Lezcano E, Zamacona J, Madoz P.

Mov Disord. 2005 Oct;20(10):1310-5.

PMID:
16001411
37.

Use of ziprasidone in parkinsonian patients with psychosis.

Gómez-Esteban JC, Zarranz JJ, Velasco F, Lezcano E, Lachen MC, Rouco I, Barcena J, Boyero S, Ciordia R, Allue I.

Clin Neuropharmacol. 2005 May-Jun;28(3):111-4.

PMID:
15965308
38.

A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease.

Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atarés B, Puig B, Gómez-Esteban JC, Fernández-Maiztegui C, Rouco I, Pérez-Concha T, Fernández M, Rodríguez O, Rodríguez-Martínez AB, de Pancorbo MM, Pastor P, Pérez-Tur J.

Neurology. 2005 May 10;64(9):1578-85.

PMID:
15883319
39.

[Baroreflex failure after chemodectoma resection].

Gómez Esteban JC, Boyero S, Fernández C, Sagasta A, Pérez T, Velasco F, Allue I, Lezcano E, Zarranz JJ.

Neurologia. 2004 Oct;19(8):452-5. Spanish.

PMID:
15470587
40.

Familial prion diseases in the Basque Country (Spain).

Zarranz JJ, Digon A, Atarés B, Arteagoitia JM, Carrera N, Fernández-Manchola I, Fernández-Martínez M, Fernández-Maiztegui C, Forcadas I, Galdos L, Ibáñez A, Lezcano E, Martí-Massó JF, Mendibe MM, Urtasun M, Uterga JM, Saracibar N, Velasco F, González de Galdeano L.

Neuroepidemiology. 2005;24(1-2):103-9. Epub 2004 Sep 24.

PMID:
15459517
41.

Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report.

Lezcano E, Gómez-Esteban JC, Zarranz JJ, Alcaraz R, Atarés B, Bilbao G, Garibi J, Lambarri I.

Mov Disord. 2004 Aug;19(8):973-7.

PMID:
15300669
42.

Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep-brain stimulation in subthalamic nucleus.

Lezcano E, Gómez-Esteban JC, Zarranz JJ, Lambarri I, Madoz P, Bilbao G, Pomposo I, Garibi J.

Eur J Neurol. 2004 Jul;11(7):451-4.

PMID:
15257682
43.

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG.

Ann Neurol. 2004 Feb;55(2):164-73.

PMID:
14755719
44.

[Bilateral subthalamic nucleus deep-brain stimulation (STN-DBS) in Parkinson's disease: initial experience in Cruces Hospital].

Lezcano E, Gómez JC, Lambarri I, Bilbao G, Pomposo I, Rodríguez O, Villoria R, Zarranz JJ, Madoz P, Garibi J.

Neurologia. 2003 May;18(4):187-95. Spanish.

PMID:
12721863
45.

[Neuropsychological changes and bilateral subthalamic deep brain stimulation in Parkinson's disease].

Gómez JC, Lezcano E, Molano A, Lambarri I, Bilbao G, Garibi J, Madoz P, Zarranz JJ.

Neurologia. 2003 Apr;18(3):139-45. Spanish.

PMID:
12677479
46.

[Unilateral optic neuropathy associated to a dural arterio-venous fistula].

Gómez Esteban JC, Lezcano E, Velasco F, Pérez Bas M, Rouco I, Zarranz JJ, Hernando I.

Neurologia. 2001 Apr;16(4):176-80. Spanish.

PMID:
11412712
47.
48.

[Posterior cortical atrophy with progressive visual agnosia].

Zarranz JJ, Lasa A, Fernández M, Lezcano E, Pérez Bas M, Varona L, Ruiz J, Beristain X.

Neurologia. 1995 Mar;10(3):119-26. Spanish.

PMID:
7756009

Supplemental Content

Loading ...
Support Center